se of Probiotics in preventing Side Effects of Radiotherapy in Patients of Oral and Pelvic Cancers.

Phase 3

Not yet recruiting

• Registration Number: CTRI/2022/06/043515
• Lead Sponsor: Indian Council of Medical Research

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2 August 2022

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1.Biopsy proven cases of Head & Neck Cancers (HNCs) and pelvic malignancies including Carcinoma Cervix, Carcinoma Urinary Bladder & Carcinoma Anorectum

2.Age >=18 years

3.Karnofsky Performance Status (KPS) > 60%

4.No prior mucositis

5.No prior history of chemo/radiotherapy administration

6.No prior probiotics and/or antibiotics intake (at least within preceding 15 days) study)

Exclusion Criteria

1.Patients who refuse to give their consent

2.Serious co-morbid diseases

3.Prostate and colon malignancies (different treatment modalities)

4.History of any prior cancer, or coexisting tumors (2nd primaries)

5.Prior treatment history (Chemo/radiotherapy/surgery)

6.Patients with Immunity diseases (Autoimmunity/ Immunodeficiency)

7.Inability to take medicine orally or absorb medicine in GIT

8.Allergy to probiotics.

Study & Design

• Study Type: Interventional
• Study Design: Not specified